array:25 [
  "pii" => "S1578219019303506"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2018.06.030"
  "estado" => "S300"
  "fechaPublicacion" => "2020-01-01"
  "aid" => "2216"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2019"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "sco"
  "cita" => "Actas Dermosifiliogr. 2020;111:67-8"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:20 [
      "pii" => "S0001731019301814"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2018.06.020"
      "estado" => "S300"
      "fechaPublicacion" => "2020-01-01"
      "aid" => "2216"
      "copyright" => "AEDV"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "sco"
      "cita" => "Actas Dermosifiliogr. 2020;111:67-8"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 39
        "formatos" => array:2 [
          "HTML" => 24
          "PDF" => 15
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Foro de Residentes</span>"
        "titulo" => "FR-Nueva vacuna recombinante para la prevenci&#243;n del herpes z&#243;ster"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "67"
            "paginaFinal" => "68"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "RF-New Recombinant Vaccine for the Prevention of Herpes Zoster"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "D&#46; Morgado-Carrasco, X&#46; Fust&#224;-Novell, P&#46; Giavedoni"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "D&#46;"
                "apellidos" => "Morgado-Carrasco"
              ]
              1 => array:2 [
                "nombre" => "X&#46;"
                "apellidos" => "Fust&#224;-Novell"
              ]
              2 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Giavedoni"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219019303506"
          "doi" => "10.1016/j.adengl.2018.06.030"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019303506?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301814?idApp=UINPBA000044"
      "url" => "/00017310/0000011100000001/v3_202009190630/S0001731019301814/v3_202009190630/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S1578219019301088"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2019.03.014"
    "estado" => "S300"
    "fechaPublicacion" => "2020-01-01"
    "aid" => "2122"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2020;111:69"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Images in Dermatology</span>"
      "titulo" => "Alopecia in Meralgia Paresthetica"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "69"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Alopecia en meralgia parest&#233;sica"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:6 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 835
              "Ancho" => 905
              "Tamanyo" => 147455
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "B&#46; Monteagudo, S&#46; Pe&#241;a-L&#243;pez, D&#46; Santos-Garc&#237;a"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "B&#46;"
              "apellidos" => "Monteagudo"
            ]
            1 => array:2 [
              "nombre" => "S&#46;"
              "apellidos" => "Pe&#241;a-L&#243;pez"
            ]
            2 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Santos-Garc&#237;a"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731018305489"
        "doi" => "10.1016/j.ad.2018.03.026"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018305489?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019301088?idApp=UINPBA000044"
    "url" => "/15782190/0000011100000001/v2_202004200619/S1578219019301088/v2_202004200619/en/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S1578219019303427"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2019.11.001"
    "estado" => "S300"
    "fechaPublicacion" => "2020-01-01"
    "aid" => "2237"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2020;111:65-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case for Diagnosis</span>"
      "titulo" => "Pitting Edema of the Face&#44; An Important Differential Diagnosis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "65"
          "paginaFinal" => "66"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Edema facial con f&#243;vea&#44; un importante diagn&#243;stico diferencial"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 755
              "Ancho" => 506
              "Tamanyo" => 67906
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Facial pitting erythematous edema&#44; predominantly on the left side&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J&#46;G&#46; Chalela, M&#46;I&#46; Gonz&#225;lez, M&#46;F&#46; Ord&#243;&#241;ez Rubiano"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "J&#46;G&#46;"
              "apellidos" => "Chalela"
            ]
            1 => array:2 [
              "nombre" => "M&#46;I&#46;"
              "apellidos" => "Gonz&#225;lez"
            ]
            2 => array:2 [
              "nombre" => "M&#46;F&#46;"
              "apellidos" => "Ord&#243;&#241;ez Rubiano"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731019302236"
        "doi" => "10.1016/j.ad.2018.04.018"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019302236?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019303427?idApp=UINPBA000044"
    "url" => "/15782190/0000011100000001/v2_202004200619/S1578219019303427/v2_202004200619/en/main.assets"
  ]
  "en" => array:16 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Resident&#8217;s Forum</span>"
    "titulo" => "Vaccine for the Prevention of Herpes Zoster"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "67"
        "paginaFinal" => "68"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "D&#46; Morgado-Carrasco, X&#46; Fust&#224;-Novell, P&#46; Giavedoni"
        "autores" => array:3 [
          0 => array:4 [
            "nombre" => "D&#46;"
            "apellidos" => "Morgado-Carrasco"
            "email" => array:1 [
              0 => "morgado@clinic.cat"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "X&#46;"
            "apellidos" => "Fust&#224;-Novell"
          ]
          2 => array:2 [
            "nombre" => "P&#46;"
            "apellidos" => "Giavedoni"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Cl&#237;nic de Barcelona&#44; Universitat de Barcelona&#44; Barcelona&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "FR-Nueva vacuna recombinante para la prevenci&#243;n del herpes z&#243;ster"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Herpes zoster is caused by reactivation of the varicella zoster virus&#44; which is characterized by a generally localized and painful vesicular skin rash&#46; Its incidence has increased in recent decades&#46; The most frequent complication is postherpetic neuralgia&#44; which affects around 18&#37; of patients with herpes zoster and may cause disabling pain&#46; The incidence of both conditions clearly increases with age&#46; Postherpetic neuralgia affects more than 30&#37; of persons with herpes zoster aged &#62;79 years&#46; The attenuated varicella zoster virus vaccine &#40;aVZV&#41; has an efficacy of 51&#37; for prevention of herpes zoster&#59; this efficacy decreases with age&#46; The vaccine is contraindicated in immunocompromised patients and approved by the United States Food and Drug Administration &#40;FDA&#41; for this indication in immunocompetent patients aged &#8805;50 years&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The FDA recently approved a new recombinant vaccine for treatment of herpes zoster &#40;rVZV&#41; &#40;Shingrix&#44; GlaxoSmithKline&#41;&#46; rVZV contains recombinant glycoprotein E of the varicella zoster virus&#44; together with the adjuvant AS01<span class="elsevierStyleInf">B</span>&#44; and is administered in 2 subcutaneous injections separated by 2&#8211;6 months &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; The efficacy of rVZV was evaluated in 2 phase 3 randomized&#44; placebo-controlled clinical trials &#40;ZOE-50<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> and ZOE-70<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a>&#41;&#46; Median follow-up was longer than 3 years in both trials&#46; ZOE-50 included 15 411 patients aged &#8805;50 years and reported 6 cases of herpes zoster in the vaccinated group compared with 210 in the placebo group&#46; Overall efficacy in the prevention of herpes zoster was 97&#46;2&#37; &#40;95&#37; CI&#44; 93&#46;7&#8211;99&#46;0&#37;&#59; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> ZOE-70 included 13 900 patients aged &#8805;70 years&#46; Efficacy was 89&#46;8&#37; &#40;95&#37; CI&#44; 84&#46;2&#8211;93&#46;7&#37;&#59; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41; for prevention of herpes zoster and 88&#46;8&#37; &#40;95&#37; CI&#44; 68&#46;7&#8211;97&#46;1&#37;&#59; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41; for prevention of postherpetic neuralgia&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> A pooled analysis of both studies showed that efficacy was 93&#46;7&#37; &#40;95&#37; CI&#44; 59&#46;5&#8211;99&#46;9&#37;&#41; for the prevention of post&#8211;herpes zoster complications other than postherpetic neuralgia&#44; i&#46;e&#46;&#44; disseminated herpes zoster&#44; secondary vasculitis&#44; encephalic vascular accident&#44; and ophthalmic&#44; neurologic&#44; and visceral disease&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> In both studies&#44; the frequency of adverse events was similar in the vaccination and placebo groups&#46; The most frequent adverse events were injection site pain&#44; myalgia&#44; and fatigue&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">rVZV has proven more successful than aVZV for prevention of herpes zoster and postherpetic neuralgia&#46; Furthermore&#44; the cost-effectiveness analysis favored rVZV over aVZV&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Consequently&#44; the Advisory Committee on Immunization Practices in the United States recently recommended rVZV for immunocompetent patients aged &#8805;50 years&#44; even in those previously vaccinated with aVZV and those who have had herpes zoster&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Evidence remains insufficient to recommend rVZV in immunocompetent patients or patients who are receiving immunosuppressive treatment with prednisone &#8805;20 mg&#47;d&#44; although it could&#44; in theory&#44; be administered&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">rVZV is an efficacious and safe alternative for prevention of herpes zoster and postherpetic neuralgia and should be recommended in adults&#46; It could thus help to reduce the morbidity associated with these conditions&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2018-05-18"
    "fechaAceptado" => "2018-06-25"
    "PalabrasClave" => array:1 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1223716"
          "palabras" => array:6 [
            0 => "Herpes zoster vaccine"
            1 => "Recombinant vaccine"
            2 => "Adyuvanted"
            3 => "Herpes zoster"
            4 => "Post herpetic neuralgia"
            5 => "Shingrix&#174;"
          ]
        ]
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Please cite this article as&#58; Morgado-Carrasco D&#44; Fust&#224;-Novell X&#44; Giavedoni P&#46; FR-Nueva vacuna recombinante para la prevenci&#243;n del herpes z&#243;ster&#46; Actas Dermosifiliogr&#46; 2020&#59;111&#58;67&#8211;68&#46;</p>"
      ]
    ]
    "multimedia" => array:1 [
      0 => array:9 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "fuente" => "Source&#58; Dooling et al&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a>"
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0015"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Abbreviations&#58; HZ&#44; herpes zoster&#59; HZ&#47;su&#44; HZ&#47;subunit&#59; aVZV&#44; attenuated varicella zoster vaccine&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Composition&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Administration&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Target Patients&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Special Situations&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Coadministration&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Recombinant glycoprotein E of varicella zoster virus&#44; which is essential for viral replication and propagation and is the target of the specific immune response&#46; Adjuvant AS01<span class="elsevierStyleInf">B</span> &#40;HZ&#47;su&#41;&#44; which promotes a marked and prolonged CD4 response to recombinant proteins&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Two subcutaneous injections separated by 2&#8211;6<span class="elsevierStyleHsp" style=""></span>mo&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Adults aged &#8805;50 y&#44; even if they have been previously vaccinated with aVZV or affected by HZ&#46; Serological screening for varicella is not recommended&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Not currently recommended for pregnant women&#46; Patients with chronic diseases &#40;chronic kidney failure&#44; diabetes mellitus&#44; chronic lung disease&#41; should be vaccinated&#46; Patients experiencing an acute episode of HZ should not be vaccinated until resolution of the acute phase&#46; Patients receiving prednisone &#60;20<span class="elsevierStyleHsp" style=""></span>mg&#47;d should be vaccinated&#46; Immunocompromised patients or patients receiving prednisone &#8805;20<span class="elsevierStyleHsp" style=""></span>mg&#47;d should not be vaccinated<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Can be coadministered with other vaccines in adults&#46; Should be injected at different sites&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2275671.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Evidence remains insufficient to recommend vaccination in immunocompetent patients&#44; although it is possible in theory&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Characteristics and Indications of the Recombinant Herpes Zoster Vaccine &#40;Shingrix&#41;&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46; Lal"
                            1 => "A&#46;L&#46; Cunningham"
                            2 => "O&#46; Godeaux"
                            3 => "R&#46; Chlibek"
                            4 => "J&#46; Diez-Domingo"
                            5 => "S&#46;-J&#46; Hwang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1501184"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2015"
                        "volumen" => "372"
                        "paginaInicial" => "2087"
                        "paginaFinal" => "2096"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25916341"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;L&#46; Cunningham"
                            1 => "H&#46; Lal"
                            2 => "M&#46; Kovac"
                            3 => "R&#46; Chlibek"
                            4 => "S&#46;-J&#46; Hwang"
                            5 => "J&#46; D&#237;ez-Domingo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2016"
                        "volumen" => "375"
                        "paginaInicial" => "1019"
                        "paginaFinal" => "1032"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Complications of herpes zoster in immunocompetent older adults&#58; Incidence in vaccine and placebo groups in two large phase 3 trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Kovac"
                            1 => "H&#46; Lal"
                            2 => "A&#46;L&#46; Cunningham"
                            3 => "M&#46;J&#46; Levin"
                            4 => "R&#46;W&#46; Johnson"
                            5 => "L&#46; Campora"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.vaccine.2018.02.029"
                      "Revista" => array:6 [
                        "tituloSerie" => "Vaccine"
                        "fecha" => "2018"
                        "volumen" => "36"
                        "paginaInicial" => "1537"
                        "paginaFinal" => "1541"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29463421"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "P&#46; Le"
                            1 => "M&#46;B&#46; Rothberg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jamainternmed.2017.7431"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA Intern Med"
                        "fecha" => "2018"
                        "volumen" => "178"
                        "paginaInicial" => "248"
                        "paginaFinal" => "258"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29297049"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;L&#46; Dooling"
                            1 => "A&#46; Guo"
                            2 => "M&#46; Patel"
                            3 => "G&#46;M&#46; Lee"
                            4 => "K&#46; Moore"
                            5 => "E&#46;A&#46; Belongia"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.15585/mmwr.mm6703a5"
                      "Revista" => array:6 [
                        "tituloSerie" => "MMWR Morb Mortal Wkly Rep"
                        "fecha" => "2018"
                        "volumen" => "67"
                        "paginaInicial" => "103"
                        "paginaFinal" => "108"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29370152"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000011100000001/v2_202004200619/S1578219019303506/v2_202004200619/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "34945"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Resident&#39;s Forum"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011100000001/v2_202004200619/S1578219019303506/v2_202004200619/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019303506?idApp=UINPBA000044"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Resident’s Forum
Vaccine for the Prevention of Herpes Zoster
FR-Nueva vacuna recombinante para la prevención del herpes zóster
D. Morgado-Carrasco
Corresponding author
morgado@clinic.cat

Corresponding author.
, X. Fustà-Novell, P. Giavedoni
Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain
Read
4843
Times
was read the article
1727
Total PDF
3116
Total HTML
Share statistics
 array:25 [
  "pii" => "S1578219019303506"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2018.06.030"
  "estado" => "S300"
  "fechaPublicacion" => "2020-01-01"
  "aid" => "2216"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2019"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "sco"
  "cita" => "Actas Dermosifiliogr. 2020;111:67-8"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:20 [
      "pii" => "S0001731019301814"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2018.06.020"
      "estado" => "S300"
      "fechaPublicacion" => "2020-01-01"
      "aid" => "2216"
      "copyright" => "AEDV"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "sco"
      "cita" => "Actas Dermosifiliogr. 2020;111:67-8"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 39
        "formatos" => array:2 [
          "HTML" => 24
          "PDF" => 15
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Foro de Residentes</span>"
        "titulo" => "FR-Nueva vacuna recombinante para la prevenci&#243;n del herpes z&#243;ster"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "67"
            "paginaFinal" => "68"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "RF-New Recombinant Vaccine for the Prevention of Herpes Zoster"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "D&#46; Morgado-Carrasco, X&#46; Fust&#224;-Novell, P&#46; Giavedoni"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "D&#46;"
                "apellidos" => "Morgado-Carrasco"
              ]
              1 => array:2 [
                "nombre" => "X&#46;"
                "apellidos" => "Fust&#224;-Novell"
              ]
              2 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Giavedoni"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219019303506"
          "doi" => "10.1016/j.adengl.2018.06.030"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019303506?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301814?idApp=UINPBA000044"
      "url" => "/00017310/0000011100000001/v3_202009190630/S0001731019301814/v3_202009190630/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S1578219019301088"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2019.03.014"
    "estado" => "S300"
    "fechaPublicacion" => "2020-01-01"
    "aid" => "2122"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2020;111:69"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Images in Dermatology</span>"
      "titulo" => "Alopecia in Meralgia Paresthetica"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "69"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Alopecia en meralgia parest&#233;sica"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:6 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 835
              "Ancho" => 905
              "Tamanyo" => 147455
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "B&#46; Monteagudo, S&#46; Pe&#241;a-L&#243;pez, D&#46; Santos-Garc&#237;a"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "B&#46;"
              "apellidos" => "Monteagudo"
            ]
            1 => array:2 [
              "nombre" => "S&#46;"
              "apellidos" => "Pe&#241;a-L&#243;pez"
            ]
            2 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Santos-Garc&#237;a"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731018305489"
        "doi" => "10.1016/j.ad.2018.03.026"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018305489?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019301088?idApp=UINPBA000044"
    "url" => "/15782190/0000011100000001/v2_202004200619/S1578219019301088/v2_202004200619/en/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S1578219019303427"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2019.11.001"
    "estado" => "S300"
    "fechaPublicacion" => "2020-01-01"
    "aid" => "2237"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2020;111:65-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case for Diagnosis</span>"
      "titulo" => "Pitting Edema of the Face&#44; An Important Differential Diagnosis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "65"
          "paginaFinal" => "66"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Edema facial con f&#243;vea&#44; un importante diagn&#243;stico diferencial"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 755
              "Ancho" => 506
              "Tamanyo" => 67906
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Facial pitting erythematous edema&#44; predominantly on the left side&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J&#46;G&#46; Chalela, M&#46;I&#46; Gonz&#225;lez, M&#46;F&#46; Ord&#243;&#241;ez Rubiano"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "J&#46;G&#46;"
              "apellidos" => "Chalela"
            ]
            1 => array:2 [
              "nombre" => "M&#46;I&#46;"
              "apellidos" => "Gonz&#225;lez"
            ]
            2 => array:2 [
              "nombre" => "M&#46;F&#46;"
              "apellidos" => "Ord&#243;&#241;ez Rubiano"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731019302236"
        "doi" => "10.1016/j.ad.2018.04.018"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019302236?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019303427?idApp=UINPBA000044"
    "url" => "/15782190/0000011100000001/v2_202004200619/S1578219019303427/v2_202004200619/en/main.assets"
  ]
  "en" => array:16 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Resident&#8217;s Forum</span>"
    "titulo" => "Vaccine for the Prevention of Herpes Zoster"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "67"
        "paginaFinal" => "68"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "D&#46; Morgado-Carrasco, X&#46; Fust&#224;-Novell, P&#46; Giavedoni"
        "autores" => array:3 [
          0 => array:4 [
            "nombre" => "D&#46;"
            "apellidos" => "Morgado-Carrasco"
            "email" => array:1 [
              0 => "morgado@clinic.cat"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "X&#46;"
            "apellidos" => "Fust&#224;-Novell"
          ]
          2 => array:2 [
            "nombre" => "P&#46;"
            "apellidos" => "Giavedoni"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Cl&#237;nic de Barcelona&#44; Universitat de Barcelona&#44; Barcelona&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "FR-Nueva vacuna recombinante para la prevenci&#243;n del herpes z&#243;ster"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Herpes zoster is caused by reactivation of the varicella zoster virus&#44; which is characterized by a generally localized and painful vesicular skin rash&#46; Its incidence has increased in recent decades&#46; The most frequent complication is postherpetic neuralgia&#44; which affects around 18&#37; of patients with herpes zoster and may cause disabling pain&#46; The incidence of both conditions clearly increases with age&#46; Postherpetic neuralgia affects more than 30&#37; of persons with herpes zoster aged &#62;79 years&#46; The attenuated varicella zoster virus vaccine &#40;aVZV&#41; has an efficacy of 51&#37; for prevention of herpes zoster&#59; this efficacy decreases with age&#46; The vaccine is contraindicated in immunocompromised patients and approved by the United States Food and Drug Administration &#40;FDA&#41; for this indication in immunocompetent patients aged &#8805;50 years&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The FDA recently approved a new recombinant vaccine for treatment of herpes zoster &#40;rVZV&#41; &#40;Shingrix&#44; GlaxoSmithKline&#41;&#46; rVZV contains recombinant glycoprotein E of the varicella zoster virus&#44; together with the adjuvant AS01<span class="elsevierStyleInf">B</span>&#44; and is administered in 2 subcutaneous injections separated by 2&#8211;6 months &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; The efficacy of rVZV was evaluated in 2 phase 3 randomized&#44; placebo-controlled clinical trials &#40;ZOE-50<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> and ZOE-70<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a>&#41;&#46; Median follow-up was longer than 3 years in both trials&#46; ZOE-50 included 15 411 patients aged &#8805;50 years and reported 6 cases of herpes zoster in the vaccinated group compared with 210 in the placebo group&#46; Overall efficacy in the prevention of herpes zoster was 97&#46;2&#37; &#40;95&#37; CI&#44; 93&#46;7&#8211;99&#46;0&#37;&#59; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> ZOE-70 included 13 900 patients aged &#8805;70 years&#46; Efficacy was 89&#46;8&#37; &#40;95&#37; CI&#44; 84&#46;2&#8211;93&#46;7&#37;&#59; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41; for prevention of herpes zoster and 88&#46;8&#37; &#40;95&#37; CI&#44; 68&#46;7&#8211;97&#46;1&#37;&#59; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41; for prevention of postherpetic neuralgia&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> A pooled analysis of both studies showed that efficacy was 93&#46;7&#37; &#40;95&#37; CI&#44; 59&#46;5&#8211;99&#46;9&#37;&#41; for the prevention of post&#8211;herpes zoster complications other than postherpetic neuralgia&#44; i&#46;e&#46;&#44; disseminated herpes zoster&#44; secondary vasculitis&#44; encephalic vascular accident&#44; and ophthalmic&#44; neurologic&#44; and visceral disease&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> In both studies&#44; the frequency of adverse events was similar in the vaccination and placebo groups&#46; The most frequent adverse events were injection site pain&#44; myalgia&#44; and fatigue&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">rVZV has proven more successful than aVZV for prevention of herpes zoster and postherpetic neuralgia&#46; Furthermore&#44; the cost-effectiveness analysis favored rVZV over aVZV&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Consequently&#44; the Advisory Committee on Immunization Practices in the United States recently recommended rVZV for immunocompetent patients aged &#8805;50 years&#44; even in those previously vaccinated with aVZV and those who have had herpes zoster&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Evidence remains insufficient to recommend rVZV in immunocompetent patients or patients who are receiving immunosuppressive treatment with prednisone &#8805;20 mg&#47;d&#44; although it could&#44; in theory&#44; be administered&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">rVZV is an efficacious and safe alternative for prevention of herpes zoster and postherpetic neuralgia and should be recommended in adults&#46; It could thus help to reduce the morbidity associated with these conditions&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2018-05-18"
    "fechaAceptado" => "2018-06-25"
    "PalabrasClave" => array:1 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1223716"
          "palabras" => array:6 [
            0 => "Herpes zoster vaccine"
            1 => "Recombinant vaccine"
            2 => "Adyuvanted"
            3 => "Herpes zoster"
            4 => "Post herpetic neuralgia"
            5 => "Shingrix&#174;"
          ]
        ]
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Please cite this article as&#58; Morgado-Carrasco D&#44; Fust&#224;-Novell X&#44; Giavedoni P&#46; FR-Nueva vacuna recombinante para la prevenci&#243;n del herpes z&#243;ster&#46; Actas Dermosifiliogr&#46; 2020&#59;111&#58;67&#8211;68&#46;</p>"
      ]
    ]
    "multimedia" => array:1 [
      0 => array:9 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "fuente" => "Source&#58; Dooling et al&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a>"
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0015"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Abbreviations&#58; HZ&#44; herpes zoster&#59; HZ&#47;su&#44; HZ&#47;subunit&#59; aVZV&#44; attenuated varicella zoster vaccine&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Composition&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Administration&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Target Patients&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Special Situations&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Coadministration&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Recombinant glycoprotein E of varicella zoster virus&#44; which is essential for viral replication and propagation and is the target of the specific immune response&#46; Adjuvant AS01<span class="elsevierStyleInf">B</span> &#40;HZ&#47;su&#41;&#44; which promotes a marked and prolonged CD4 response to recombinant proteins&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Two subcutaneous injections separated by 2&#8211;6<span class="elsevierStyleHsp" style=""></span>mo&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Adults aged &#8805;50 y&#44; even if they have been previously vaccinated with aVZV or affected by HZ&#46; Serological screening for varicella is not recommended&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Not currently recommended for pregnant women&#46; Patients with chronic diseases &#40;chronic kidney failure&#44; diabetes mellitus&#44; chronic lung disease&#41; should be vaccinated&#46; Patients experiencing an acute episode of HZ should not be vaccinated until resolution of the acute phase&#46; Patients receiving prednisone &#60;20<span class="elsevierStyleHsp" style=""></span>mg&#47;d should be vaccinated&#46; Immunocompromised patients or patients receiving prednisone &#8805;20<span class="elsevierStyleHsp" style=""></span>mg&#47;d should not be vaccinated<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Can be coadministered with other vaccines in adults&#46; Should be injected at different sites&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2275671.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Evidence remains insufficient to recommend vaccination in immunocompetent patients&#44; although it is possible in theory&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Characteristics and Indications of the Recombinant Herpes Zoster Vaccine &#40;Shingrix&#41;&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46; Lal"
                            1 => "A&#46;L&#46; Cunningham"
                            2 => "O&#46; Godeaux"
                            3 => "R&#46; Chlibek"
                            4 => "J&#46; Diez-Domingo"
                            5 => "S&#46;-J&#46; Hwang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1501184"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2015"
                        "volumen" => "372"
                        "paginaInicial" => "2087"
                        "paginaFinal" => "2096"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25916341"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;L&#46; Cunningham"
                            1 => "H&#46; Lal"
                            2 => "M&#46; Kovac"
                            3 => "R&#46; Chlibek"
                            4 => "S&#46;-J&#46; Hwang"
                            5 => "J&#46; D&#237;ez-Domingo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2016"
                        "volumen" => "375"
                        "paginaInicial" => "1019"
                        "paginaFinal" => "1032"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Complications of herpes zoster in immunocompetent older adults&#58; Incidence in vaccine and placebo groups in two large phase 3 trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Kovac"
                            1 => "H&#46; Lal"
                            2 => "A&#46;L&#46; Cunningham"
                            3 => "M&#46;J&#46; Levin"
                            4 => "R&#46;W&#46; Johnson"
                            5 => "L&#46; Campora"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.vaccine.2018.02.029"
                      "Revista" => array:6 [
                        "tituloSerie" => "Vaccine"
                        "fecha" => "2018"
                        "volumen" => "36"
                        "paginaInicial" => "1537"
                        "paginaFinal" => "1541"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29463421"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "P&#46; Le"
                            1 => "M&#46;B&#46; Rothberg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jamainternmed.2017.7431"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA Intern Med"
                        "fecha" => "2018"
                        "volumen" => "178"
                        "paginaInicial" => "248"
                        "paginaFinal" => "258"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29297049"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;L&#46; Dooling"
                            1 => "A&#46; Guo"
                            2 => "M&#46; Patel"
                            3 => "G&#46;M&#46; Lee"
                            4 => "K&#46; Moore"
                            5 => "E&#46;A&#46; Belongia"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.15585/mmwr.mm6703a5"
                      "Revista" => array:6 [
                        "tituloSerie" => "MMWR Morb Mortal Wkly Rep"
                        "fecha" => "2018"
                        "volumen" => "67"
                        "paginaInicial" => "103"
                        "paginaFinal" => "108"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29370152"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000011100000001/v2_202004200619/S1578219019303506/v2_202004200619/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "34945"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Resident&#39;s Forum"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011100000001/v2_202004200619/S1578219019303506/v2_202004200619/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019303506?idApp=UINPBA000044"
]
Article information
ISSN: 15782190
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 9 7 16
2024 October 105 50 155
2024 September 89 31 120
2024 August 135 57 192
2024 July 109 32 141
2024 June 103 67 170
2024 May 111 41 152
2024 April 131 27 158
2024 March 111 32 143
2024 February 95 32 127
2024 January 95 32 127
2023 December 75 17 92
2023 November 111 27 138
2023 October 67 21 88
2023 September 78 29 107
2023 August 44 20 64
2023 July 65 31 96
2023 June 73 22 95
2023 May 68 30 98
2023 April 56 18 74
2023 March 66 26 92
2023 February 41 20 61
2023 January 47 27 74
2022 December 42 34 76
2022 November 40 27 67
2022 October 33 22 55
2022 September 24 38 62
2022 August 56 35 91
2022 July 40 47 87
2022 June 42 28 70
2022 May 32 36 68
2022 April 37 30 67
2022 March 42 51 93
2022 February 45 38 83
2022 January 26 33 59
2021 December 23 40 63
2021 November 40 46 86
2021 October 44 60 104
2021 September 44 45 89
2021 August 26 30 56
2021 July 30 23 53
2021 June 40 19 59
2021 May 44 31 75
2021 April 64 64 128
2021 March 48 26 74
2021 February 40 21 61
2021 January 33 21 54
2020 December 27 29 56
2020 November 31 22 53
2020 October 25 16 41
2020 September 28 15 43
2020 August 39 19 58
2020 July 20 13 33
2020 June 21 20 41
2020 May 37 19 56
2020 April 46 24 70
2020 March 21 9 30
2020 February 2 0 2
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?